Onglyza Heart Failure Lawsuit Filed in New Jersey

A man from New Jersey who allegedly suffered catastrophic heart damage after taking saxagliptin, the active ingredient in the diabetes drugs Onglyza and Kombiglyze XR, has filed a products liability lawsuit against Bristol-Myers Squibb and Astrazeneca Pharmaceuticals.

Free Confidential Lawsuit Evaluation: If you or a loved one has been injured by Onglyza side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

July 24, 2017 – Plaintiff Earl Binns claims in the lawsuit that he developed coronary artery disease and congestive heart failure as a result of taking saxagliptin. Binns further alleges that Bristol-Myers Squibb and AstraZeneca are responsible for his injuries because the companies knew there was a “significant, increased risk” of adverse events associated with saxagliptin.

“Despite such knowledge, defendants knowingly, purposely and deliberately failed to adequately warn plaintiff, patients, consumers, medical providers and the public of the increased risk of serious injury associated with using Saxagliptin including but not limited to heart failure, congestive heart failure, cardiac failure, and death related to those events,” the lawsuit states.

Saxagliptin is used to help lower blood sugar levels in patients with type 2 diabetes. The U.S. Food & Drug Administration (FDA) approved Onglyza in July 2009, and Kombiglyze XR in November 2010.

In April 2016, FDA issued a drug safety communication warning that saxagliptin and alogliptin, another similar diabetes drug, could increase the risk of heart failure.

“Type 2 diabetes medicines containing saxagliptin and alogliptin may increase the risk of heart failure, particularly in patients who already have heart or kidney disease,” the agency said. “Heart failure can result in the heart not being able to pump enough blood to meet the body’s needs.”

Binns’ complaint was filed on May 2 in the U.S. District Court, District of New Jersey, under case number 3:17-cv-30328.

Do I Have an Onglyza Class Action Lawsuit?

The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Onglyza lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

Free Case Evaluation: Again, if you were harmed by the side effects of a diabetes medication, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.